LENZ Therapeutics, Inc. Common Stock
LENZ •
Sell Open
Signal type
Sell
Status
Open
Open Price
$11.21
Stop Loss
$14.89
Performance
11.69%
Days Open
37
Signal Setup
Signal Type Sell
Status Open
Open Date Mar 9, 2026
Open Price $11.21
Stop Loss $14.89
Timespan Day
Company Profile
Name LENZ Therapeutics, Inc. Common Stock
Ticker LENZ
Market Cap $845.79M
Sector BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Latest Close $9.90
List Date Mar 22, 2024
Description
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
Website Open Company Website